Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akira Tiele has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development of a Personalised Environmental Quality Monitoring System (PONG)

    by Thomas H. Frampton, Akira Tiele, James A. Covington

    This article describes the design, development and testing of a Personalised envirONmental quality monitorinG system (referred to as PONG). The custom-built sensing solution monitors environmental factors relating to air quality (VOC and NO 2 ), light quality (UV intensity and index), acoustic comfort (ambient sound levels) and thermal comfort (temperature, humidity and pressure). Location information is also tracked for subsequent data mapping. The device transmits measurements via Bluetooth Low Energy to a nearby Android smartphone, which logs and displays the measurements to the user, on a bespoke Android application. The hardware consists of an in-house designed PCB, for microcontroller and sensors, enclosed in a 3D-printed case with a wrist-strap. The device was tested in a static location (countryside environment) and utilised as a mobile environmental tracker, worn by a volunteer. The functionality of the system was successfully demonstrated for both static and mobile testing.


  • Open Access

    Development of a Tuneable NDIR Optical Electronic Nose

    by Siavash Esfahani, Akira Tiele, Samuel O. Agbroko, James A. Covington

    Electronic nose (E-nose) technology provides an easy and inexpensive way to analyse chemical samples. In recent years, there has been increasing demand for E-noses in applications such as food safety, environmental monitoring and medical diagnostics. Currently, the majority of E-noses utilise an array of metal oxide (MOX) or conducting polymer (CP) gas sensors. However, these sensing technologies can suffer from sensor drift, poor repeatability and temperature and humidity effects. Optical gas sensors have the potential to overcome these issues. This paper reports on the development of an optical non-dispersive infrared (NDIR) E-nose, which consists of an array of four tuneable detectors, able to scan a range of wavelengths (3.1–10.5 μm). The functionality of the device was demonstrated in a series of experiments, involving gas rig tests for individual chemicals (CO2 and CH4), at different concentrations, and discriminating between chemical standards and complex mixtures. The optical gas sensor responses were shown to be linear to polynomial for different concentrations of CO2 and CH4. Good discrimination was achieved between sample groups. Optical E-nose technology therefore demonstrates significant potential as a portable and low-cost solution for a number of E-nose applications.


  • Open Access

    Sniffing Out Urinary Tract Infection—Diagnosis Based on Volatile Organic Compounds and Smell Profile

    by Valentin-Mihai Dospinescu, Akira Tiele, James A. Covington

    Current available methods for the clinical diagnosis of urinary tract infection (UTI) rely on a urine dipstick test or culturing of pathogens. The dipstick test is rapid (available in 1–2 min), but has a low positive predictive value, while culturing is time-consuming and delays diagnosis (24–72 h between sample collection and pathogen identification). Due to this delay, broad-spectrum antibiotics are often prescribed immediately. The over-prescription of antibiotics should be limited, in order to prevent the development of antimicrobial resistance. As a result, there is a growing need for alternative diagnostic tools. This paper reviews applications of chemical-analysis instruments, such as gas chromatography–mass spectrometry (GC-MS), selected ion flow tube mass spectrometry (SIFT-MS), ion mobility spectrometry (IMS), field asymmetric ion mobility spectrometry (FAIMS) and electronic noses (eNoses) used for the diagnosis of UTI. These methods analyse volatile organic compounds (VOCs) that emanate from the headspace of collected urine samples to identify the bacterial pathogen and even determine the causative agent’s resistance to different antibiotics. There is great potential for these technologies to gain wide-spread and routine use in clinical settings, since the analysis can be automated, and test results can be available within minutes after sample collection. This could significantly reduce the necessity to prescribe broad-spectrum antibiotics and allow the faster and more effective use of narrow-spectrum antibiotics.


  • Open Access

    Breath-based non-invasive diagnosis of Alzheimer’s disease: a pilot study

    by Akira Tiele, Alfian Wicaksono, Emma Daulton, Emmanuel Ifeachor, Victoria Eyre, Sophie Clarke, Leanne Timings, Stephen Pearson, James A Covington, Xinzhong Li

    Early detection of Alzheimer’s disease (AD) will help researchers to better understand the disease and develop improved treatments. Recent developments have thus focused on identifying biomarkers for mild cognitive impairment due to AD (MCI) and AD during the preclinical phase. The aim of this pilot study is to determine whether exhaled volatile organic compounds (VOCs) can be used as a non-invasive method to distinguish controls from MCI, controls from AD and to determine whether there are differences between MCI and AD. The study used gas chromatography—ion mobility spectrometry (GC-IMS) techniques. Confounding factors, such as age, smoking habits, gender and alcohol consumption are investigated to demonstrate the efficacy of results. One hundred subjects were recruited including 50 controls, 25 AD and 25 MCI patients. The subject cohort was age- and gender-matched to minimise bias. Breath samples were analysed using a commercial GC-IMS instrument (G.A.S. BreathSpec, Dortmund, Germany). Data analysis indicates that the GC-IMS signal was consistently able to separate between diagnostic groups [AUC ± 95%, sensitivity, specificity], controls versus MCI: [0.77 (0.64–0.90), 0.68, 0.80], controls versus AD: [0.83 (0.72–0.94), 0.60, 0.96], and MCI versus AD: [0.70 (0.55–0.85), 0.60, 0.84]. VOC analysis indicates that six compounds play a crucial role in distinguishing between diagnostic groups. Analysis of possible confounding factors indicate that gender, age, smoking habits and alcohol consumption have insignificant influence on breath content. This pilot study confirms the utility of exhaled breath analysis to distinguish between AD, MCI and control subjects. Thus, GC-IMS offers great potential as a non-invasive, high-throughput, diagnostic technique for diagnosing and potentially monitoring AD in a clinical setting.


  • Open Access

    Development of a Compact, IoT-Enabled Electronic Nose for Breath Analysis

    by Akira Tiele, Alfian Wicaksono, Sai Kiran Ayyala, James A. Covington

    In this paper, we report on an in-house developed electronic nose (E-nose) for use with breath analysis. The unit consists of an array of 10 micro-electro-mechanical systems (MEMS) metal oxide (MOX) gas sensors produced by seven manufacturers. Breath sampling of end-tidal breath is achieved using a heated sample tube, capable of monitoring sampling-related parameters, such as carbon dioxide (CO2), humidity, and temperature. A simple mobile app was developed to receive real-time data from the device, using Wi-Fi communication. The system has been tested using chemical standards and exhaled breath samples from healthy volunteers, before and after taking a peppermint capsule. Results from chemical testing indicate that we can separate chemical standards (acetone, isopropanol and 1-propanol) and different concentrations of isobutylene. The analysis of exhaled breath samples demonstrate that we can distinguish between pre- and post-consumption of peppermint capsules; area under the curve (AUC): 0.81, sensitivity: 0.83 (0.59–0.96), specificity: 0.72 (0.47–0.90), p-value: <0.001. The functionality of the developed device has been demonstrated with the testing of chemical standards and a simplified breath study using peppermint capsules. It is our intention to deploy this system in a UK hospital in an upcoming breath research study.


  • Open Access

    Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements

    by Akira Tiele, Anne Daly, John Hattersley, Alex Pinto, Sharon Evans, Catherine Ashmore, Anita MacDonald, James A Covington

    In clinical practice, caregivers of children with phenylketonuria (PKU) report that their children have breath malodour. This might be linked to the regular consumption of low phenylalanine (Phe)/Phe-free protein substitutes (PS), which are an essential component of a low-Phe diet. Oral malodour can negatively affect interpersonal communication, lead to bullying, low self-esteem and social isolation. In this longitudinal cross-over study, exhaled volatile organic compounds (VOCs) were measured using gas chromatography-ion mobility spectrometry. 40 children (20 PKU, 20 controls) were recruited. Subjects with PKU took either L-Amino Acid (L-AA) or Casein Glycomacropeptide (CGMP-AA) exclusively for 1 week, in a randomised order. On the seventh day, seven exhaled breath samples were collected over a 10 h period. Subjects then transferred to the other PS for a week and on day seven, provided seven further breath samples. All subjects had a standardised menu using low-Phe food alternatives and all food intake was measured and recorded. In the PKU group, the aim was to collect samples 30 min after consuming PS. In 3 subjects, breath was collected 5 min post-PS consumption. Fasted L-AA and CGMP-AA breath samples contained a similar number of VOC peaks (10-12) as controls. Longitudinal breath testing results demonstrate that there was no significant difference in the number of exhaled VOCs, comparing L-AA or CGMP-AA with controls, or between PS (12-18 VOC peaks). Breath analysed immediately after consumption of PS ( n = 3) showed an immediate increase in the number of VOC peaks (25-30), but these were no longer detectable at 30 min post-consumption. This suggests PS have a transient effect on exhaled breath. Measurements taken 30 min after consuming L-AA or CGMP-AA were not significantly different to controls. This indicates that timing food and drinks with PS consumption may be a potential solution for carers to reduce or eliminate unpleasant PS-related breath odours.


  • Development of a Thermal-Based Olfactory Display for Aroma Sensory Training

    by Akira Tiele, Siddharth Menon, James A. Covington

    The digital replication of smell – so-called olfactory displays, remains one of the least advanced sensory technologies. Recent developments have focused heavily on virtual reality. However, there remains a need for olfactory displays targeted towards aroma training. In this paper, we present a thermal-based olfactory display, using Peltier heating elements. The unit is fully computer-controlled and holds up to 12 ‘aroma capsules’. Each capsule contains an individual aroma that can either be activated on its own or with others to create richer experiences. The unit has been designed as part of a wine aroma game to promote sensory training. The portable device has been tested with 15 volunteers to test the detection and recognition times of 6 aromas associated with red or white wines.


  • Design and Development of a Novel Transtibial Cycling Prosthesis

    by Akira Tiele, Shivam Soni-Sadar, Jack Rowbottom, Shilen Patel, Edward Mathewson, Samuel Pearson, David Hutchins, John Head, Stephen Hutchins

    Introduction: This article describes the design methodology, creation, and testing of a bespoke transtibial prosthesis, manufactured in part using three-dimensional (3D) printing technology, to enable more effective transmission of dynamic pressure through pedals during cycling. Asymmetry in motion can occur during cycling between the affected and contralateral lower limb. This pilot study was devised to enable development of a prototype prosthesis using a flexible ankle joint design for people with transtibial lower-limb absence for use when participating in amateur sports cycling. Materials and Methods: Gait laboratory analysis and in-shoe plantar pressure measurement were used to simultaneously measure heel/ankle kinematics, plus pressure magnitude/distribution applied during cycling. A volunteer subject cycled on a static rig wearing either a standard unilateral transtibial prosthesis or a prototype prosthesis, which incorporated a simulated Achilles tendon. An able-bodied volunteer acted as a control. Results: The results indicate that cycling with the prototype prosthesis reduced bilateral ankle and heel kinematic misalignment by 64% and reduced unwanted pedal pressure during the cycling recovery phase from 60 N to 50 N. Conclusions: The use of 3D printing is a feasible option in the design and manufacture of lower-limb prostheses designed for cycling. Further research is needed to confirm this in a larger cohort of patients.


  • Open Access

    Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease—A Pilot Study

    by Akira Tiele, Alfian Wicaksono, Jiten Kansara, Ramesh P. Arasaradnam, James A. Covington

    Early diagnosis of inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), remains a clinical challenge with current tests being invasive and costly. The analysis of volatile organic compounds (VOCs) in exhaled breath and biomarkers in stool (faecal calprotectin (FCP)) show increasing potential as non-invasive diagnostic tools. The aim of this pilot study is to evaluate the efficacy of breath analysis and determine if FCP can be used as an additional non-invasive parameter to supplement breath results, for the diagnosis of IBD. Thirty-nine subjects were recruited (14 CD, 16 UC, 9 controls). Breath samples were analysed using an in-house built electronic nose (Wolf eNose) and commercial gas chromatograph–ion mobility spectrometer (G.A.S. BreathSpec GC-IMS). Both technologies could consistently separate IBD and controls [AUC ± 95%, sensitivity, specificity], eNose: [0.81, 0.67, 0.89]; GC-IMS: [0.93, 0.87, 0.89]. Furthermore, we could separate CD from UC, eNose: [0.88, 0.71, 0.88]; GC-IMS: [0.71, 0.86, 0.62]. Including FCP did not improve distinction between CD vs. UC; eNose: [0.74, 1.00, 0.56], but rather, improved separation of CD vs. controls and UC vs. controls; eNose: [0.77, 0.55, 1.00] and [0.72, 0.89, 0.67] without FCP, [0.81, 0.73, 0.78] and [0.90, 1.00, 0.78] with FCP, respectively. These results confirm the utility of breath analysis to distinguish between IBD-related diagnostic groups. FCP does not add significant diagnostic value to breath analysis within this study.


  • Development of a Portable, Multichannel Olfactory Display Transducer

    by James A. Covington, Samuel O. Agbroko, Akira Tiele

    In this paper, we report on the development of a simple, yet innovative multichannel olfactory display. Unlike other sensory stimuli (specifically sight and sound), digital olfactory technology has yet to have wide-spread commercial success. Our proposed system will release up to eight different liquid phase aromas (essential oils) using a thermal mechanism. The unit contains a speed controlled fan, temperature control of the heating element, and a gas sensor to provide feedback to inform the release rate. It can be connected (via Bluetooth low energy) to a tablet/computer to control the timing and intensity of the aroma. External measurements show that aromas can be detected within a few seconds of release and produce a broad range of intensities from low parts per million (ppm) to 10 s of ppm.